9th Annual Biomarkers Congress

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. Round Table: Infections in Solid Organ Transplant Patients 12th International Symposium of Infections in the Immunocompromised Host October, 2010
2. Infections and Immunization in the Renal Transplant Patient Nephrology Update, Cleveland Clinic Foundation October, 2010
3. Infections and Immunization in the Renal Transplant Patient American Society of  Nephrology Boston, Massachusetts  October, 2010
4. Infectious Diseases and the Skin Infectious Disease Grand Rounds, Cleveland Clinic Foundation October, 2010
5. Infections in the Immunocompromised Host Cleveland Clinic Foundation. October, 2010
6. What's New in Transplant ID Infectious Disease Grand Rounds, Cleveland Clinic Foundation  October, 2010
7. Liver Disease After Transplantation Infectious Disease Grand Rounds, Cleveland Clinic Foundation October, 2010
8. Unusual Causes of Lymphadenopathy Infectious  Disease Grand Rounds, Cleveland Clinic Foundation October, 2010
9. Medical Management of Renal Transplant Patients Nephrology Update 1996, Cleveland Clinic October, 2010
10. Post-Transplant Infections American Society of Transplant Physicians. Luncheon   October, 2010
11. Infections in the Immunocompromised Host Cleveland Clinic Eighth Annual Intensive Review of Internal Medicine October, 2010
12. Transplant Infectious Disease for the Generalist Martin C. McHenry Symposium October, 2010
13. Infections in the Immunocompromised patient Medical House Staff Conference October, 2010
14. Infections in Autologous Bone Marrow Transplant Recipients:  Research Update Cleveland Clinic Foundation October, 2010
15. Infectious Complications in Recipients of Autologous  Peripheral Stem Cell Transplants Medical College of Ohio, Toledo, OH October, 2010
16. Medical Management of the Renal Transplant Patient Nephrology Update 1997 Workshop Cleveland Clinic Foundation October, 2010
17. Tick-Borne Diseases 2nd Annual May Day Therapy:   Dermatology", Cleveland Clinic Foundation.  October, 2010
18. Lung Transplantation: Infections and You Second Wind Lung  Transplant Support Group October, 2010
19. Skin Infections CCF Skin Care Team October, 2010
20. Infections in the Immunocompromised Host Medical House Staff. Noon Conference October, 2010
21. Fever and Neutropenia Medical House Staff. Noon Conference October, 2010
22. Update in Transplant Infectious Disease Medical Grand Rounds, Cleveland Clinic Foundation October, 2010
23. Granulocytopenia, Immunocompromised Host, and Infections Conference at Fairview Hospital October, 2010
24. Pro-Con Debate: CMV Prophylaxis vs. Pre-Emptive Therapy Cleveland Clinic Transplant Research Day  October, 2010
25. New Developments in Transplant Infectious Disease Loyola University Medical Center Transplant ID Symposium October, 2010
26. Donor-Derived Infections and Screening AST Winter Symposium October, 2010
27. Vaccinations in transplant recipients AST Winter Symposium October, 2010
28. Vaccination of Immunocompromised Patients: Solid Organ Transplant Patients 12th International Symposium of Infections in the Immunocompromised Host October, 2010
29. Vaccinations in the Immunocompromised Patient with Rheumatologic Disease American College of Rheumatology, New Orleans, LA October, 2010
30. Update in Transplant Infectious Disease Transplant Center Rounds, Cleveland Clinic Foundation. October, 2010
31. New and Emerging Infectious Disease Pathogens in the 1990's. Medical Grand Rounds, Cleveland Clinic Foundation October, 2010
32. Infections in recipients of both thoracic and abdominal organ transplants American Transplant Congress May, 2010
33. Longitudinal Analysis of EBV, CMV, HHV-6 and HHV-7 in Pediatric SOT Recipients. American Transplant Congress May, 2010
34. A multicenter study of clinical outcomes of novel influenza A/H1N1 infection in solid organ transplant recipients American Transplant Congress May, 2010
35. MICA Polymorphism and Viral Acquisition and Reactivation in Post-Transplant Patients American Transplant Congress May, 2010
36. The value of pre-liver transplant screening by infectious disease specialists American Transplant Congress May, 2010
37. Allosensitization is associated with increased risk of infectious complications post simultaneous liver/kidney transplants American Transplant Congress May, 2010
38. CMV and other transplant-related infections Lecture for pulmonary fellows at Cleveland Clinic March, 2010
39. Serologies, Vaccines, and Exposures Lectures for transplant coordinators at Cleveland Clinic November, 2009
40. Meet the Professor Session: 10 Top Papers in Transplant ID Infectious Diseases Society of America, Philadelphia, PA. October, 2009
41. Oral maribavir for treatment of resistant or refractory cytomegalovirus infections in transplant recipients ICAAC September, 2009
42. Update on CMV and BKV Infection in Solid Organ Transplant Recipients Wayne State Transplant Infectious Disease Symposium September, 2009
43. Low ATP immune function levels may be a consequence rather than a cause of CMV viremia in liver transplant recipients. American Transplant Congress June, 2009
44. Detection of HHV-6 in archived lung biopsies from CMV D-/R- lung transplant recipients. American Transplant Congress June, 2009
45. Strategies for Safer Living After Solid Organ Transplantation Strategies for Safer Living After Solid Organ Transplantation June, 2009
46. Betaherpesviruses in pediatric organ transplantation: a longitudinal evaluation American Transplant Congress June, 2009
47. The Association between Killer Immunoglobulin-Like Receptors (KIR) Genotype Profile and Primary CMV Infection in CMV D+/R- Heart and Lung Transplant Recipients. International Society of Heart and Lung Transplantation April, 2009
48. Updates in Transplant ID Infectious Disease Grand Rounds, University of Michigan Medical Center April, 2009
49. Screening, Diagnosis, and Treatment of BK Virus Infection Dayton Transplant Symposium March, 2009
50. The inverse association between peak CMV viral load and absolute lymphocyte count in solid organ transplant recipients with primary CMV infection Infectious Diseases Society of America, ICAAC/IDSA Joint Meeting October, 2008
51. Infections in Kidney Transplant Recipients and Candidates: What the General Nephrologist Needs to Know Cardio-Renal Summit October, 2008
52. The Association Between Killer Immunoglobulin-like Receptors (KIR) Genotype Profile and Primary CMV Infection in the CMV D+/R- Solid Organ Transplant Recipient. Infectious Diseases Society of America, ICAAC/IDSA Joint Meeting October, 2008
53. Update on Infections in Renal Transplant Candidates and Recipients. Kidney Foundation of Ohio September, 2008
54. Infections in Kidney Transplant Recipients and Candidates Cleveland Clinic September, 2008
55. Infections and prophylactic therapies in liver transplant recipients. Liver Transplant Team rounds August, 2008
56. Vaccination and Prophylaxis Recommendations for Adult and Pediatric Organ Transplant Recipients American Transplant Congress, Toronto, Canada June, 2008
57. Preliminary results of the Organ Transplant Infection Project (OTIP), a multi-year cohort study of stem cell and lung transplant recipients American Transplant Congress June, 2008
58. Histoplasmosis in solid organ transplant recipients 1997-2007 American Transplant Congress June, 2008
59. The impact of pre-transplant IgG and IgA levels on early pneumonia and survival after lung transplantation American Transplant Congress June, 2008
60. Lactobacillus acidophilus may help to decrease recurrences and ameliorate severity of C. difficile-associated diarrhea in lung transplant recipients International Society for Heart and Lung Transplantation April, 2008
61. Infections in liver transplant recipients undergoing in-hospital retransplantation and/or with pre-transplant hospitalization. American Transplant Congress May, 2007
62. Long-Term Infections in Transplant Recipients American Transplant Congress (invited workshop co-moderator); San Francisco, CA May, 2007
63. Killer immunoglobulin-like receptors (KIR) genotype profile and KIR/HLA combinations in kidney and kidney-pancreas transplant recipients with viruria, viremia, and/or BK nephropathy (BKVN) American Transplant Congress May, 2007
64. MRSA infection in lung transplant recipients with cystic fibrosis American Transplant Congress May, 2007
65. Persistence of VRE infection in liver transplant recipients treated with daptomycin American Transplant Congress May, 2007
66. . Donor-Derived and New Viruses. Dimensions of Cardiac Care (invited speaker); Cleveland, OH April, 2007
67. Transplant-Transmitted Infections; Risks and Outcomes: Hepatitis C International Society of Heart and Lung Transplantation (invited speaker); San Francisco, CA April, 2007
68. Valganciclovir-associated neutropenia in lung transplant recipients Chest 2006 October, 2006
69. PCR for PCP in SOT: Alphabet soup or the next best thing? World Transplant Congress July, 2006
70. Clinical and virological outcomes of adding leflunomide to ganciclovir or foscarnet for treatment of CMV viremia in transplant recipients. World Transplant Congress July, 2006
71. Overview of Donor-Derived Infections World Transplant Congress Sunrise Symposium (invited speaker); Boston, MA. July, 2006
72. Safety of Lactobacillus acidophilus used in the treatment of Clostridium difficile colitis in transplant recipients World Transplant Congress July, 2006
73. Reduction of late CMV after prophylaxis by a combined prophylaxis/pre-emptive therapy program in high-risk transplant recipients American Transplant Congress July, 2006
74. Transplant Immunology. CCF Allergy-Immunology Grand Rounds April, 2006
75. Utility of Viral Load Monitoring for CMV and EBV in Solid Organ Transplantation CCF ID Grand Rounds November, 2005
76. Ganciclovir-resistant CMV Symposium on Infections in Cancer, MD Anderson Cancer Center October, 2005
77. Update in Pediatric Transplant Infectious Disease dinner meeting, Cleveland, organized by Dr. Ira Davis June, 2005
78. HHV-6 and Cardiac Allograft Vasculopathy Research Conference Lerner Research Institute, CCF May, 2005
79. The impact of Cytogam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study. American Transplant Congress May, 2005
80. EBV-DNA levels in lung transplant recipients who are CMV donor and recipient seronegative American Transplant Congress May, 2005
81. Use of Hepatitis B- and C-Positive Donors International Society of Heart and Lung Transplantation, Philadelphia, PA April, 2005
82. Transplant Infectious Disease for Cardiology Fellows Cardiology Fellows’ Conference, CCF March, 2005
83. Update on Transplant Infectious Disease UNOS Regional Meeting October, 2004
84. Does Antifungal Prophylaxis Work? American Thoracic Society May, 2004
85. Marked decrease in PTLD with a PTLD prevention program in adult lung transplant recipients utilizing EBV DNA monitoring American Transplant Congress May, 2004
86. EBV DNAemia and PTLD in lung transplant recipients with cystic fibrosis. American Transplant Congress May, 2004
87. Thrombotic microangiopathy (TMA) in the sirolimus era American Transplant Congress May, 2004
88. Vaccinations in solid organ transplant recipients: challenges and controversies Symposium on Vaccination in Special Populations May, 2004
89. Symposium on Hypogammaglobulinemia in Transplantation May, 2004
90. HHV-6 and Cardiac Transplantation Translational Research Conference April, 2004
91. Neutropenia in Solid Organ Transplant Recipients Treated With Valganciclovir Conference on Valganciclovir and Neutropenia, Arizona March, 2004
92. Infections In Lung Transplant Recipients Pulmonary Fellows February, 2004
93. Translational Conference: Transplant Immunosuppression and Risk for Infections. Infectious Disease Grand Rounds, Cleveland Clinic Foundation January, 2004
94. Transplant Infectious Disease Medical House Staff Noon Conference. December, 2003
95. Update in Transplant Infectious Disease Transplant Conference, CCF October, 2003
96. Respiratory viruses in lung transplant recipients American Transplant Congress June, 2003
97. Thrombotic thrombocytopenia purpura in solid organ transplantation compared with bone marrow transplantation CCF/UH Transplant Research Day May, 2003
98. Hypogammaglobulinemia in recipients of nonmyeloablative allogeneic stem cell transplants. CCF/UH Transplant Research Day May, 2003
99. Update in Transplant Infectious Disease Infectious Disease Grand Rounds, Cleveland Clinic Foundation February, 2003
100. Donor or recipient hepatitis B infection accelerates allograft vasculopathy.  A serial intravascular ultrasound study American Transplant Congress May, 2002
101. The clinical utility of CMV viral load in bronchoalveolar lavage in lung transplant recipients American Transplant Congress May, 2002
102. Antiviral activity of the experimental immunosuppressive agent leflunomide: experimental studies and a clinical case.  8th International Cytomegalovirus Workship May, 2001
103. Non-Aspergillus invasive mycelia as emerging pathogens in organ transplant reciepients. Transplant 2001 (AST/ASTS) May, 2001
104. HLA-cytomegalovirus (CMV) interaction in relations to rejection and vasculopathy following human heart transplantation Transplant 2001 (AST/ASTS) May, 2001
105. Severe hypogammaglobulinemia following heart transplantation: impact of pre-emptive use of immunoglobulin replacement (Cytogam) on infection and rejection outcomes Transplant 2001 (AST/ASTS) May, 2001
106. Risk factors for ganciclovir (GCV) resistant CMV in CMV D+/R- solid organ transplant recipients Transplant 2001 (AST/ASTS) May, 2001
107. CMV antiviral drug resistance in solid organ transplant recipients 8th International Cytomegalovirus Workship May, 2001
108. Early infectious complications in non-myeloablative allogeneic bone marrow transplant recipients (NMA-BMT) Transplant 2001 (AST/ASTS) May, 2001
109. CMV Monitoring Lung Transplant Valganciclovir Study Design Meeting, April, 2001
110. Update on CMV Resistance and CMV Prophylaxis. Talk to Liver Transplant Team April, 2001
111. Vaccinations in the Immunocompromised Patient with Rheumatologic Disease Rheumatology Grand Rounds April, 2001
112. Transplant-Related Infections Cardiac Transplant Pre-Transplant Patient Teaching Sessions March, 2001
113. Vaccinations in the Immunocompromised Patient with Rheumatologic Disease Neurology House Staff Noon Conference January, 2001
114. New Developments in Transplant Infectious Disease Nephrology Grand Rounds January, 2001
115. Incidence of invasive aspergillosis among solid organ transplant recipients at the Cleveland Clinic in the 1990's 38th Annual Meeting, Infectious Diseases Society of America September, 2000
116. Amphotericin B intravenous home infusions for prophylaxis against invasive aspergillosis in high risk allogeneic bone marrow transplant recipients.  38th Annual Meeting, Infectious Diseases Society of America September, 2000
117. Late hypogammaglobulinemia in long-term survivors of allogeneic bone marrow transplantation. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation May, 2000
118. Long-term outcomes in heart transplant recipients who received ganciclovir prophylaxis: impact of CMV and CMV serostatus on rejection, allograft vasculopathy, and survival. First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation May, 2000
119. A randomized controlled trial of short- versus long-course vancomycin as a component of an antibiotic regimen for febrile neutropenic autologous peripheral blood progenitor cell (PBPC) transplant recipients First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation May, 2000
120. Emergence of clinically significant ganciclovir (GCV)- resistant strains of CMV in solid organ transplant recipients First Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation May, 2000
121. Hypogammaglobulinemia in heart transplant recipients treated with tacrolimus, mycophenolate, and prednisone.  ASTP May, 1999
122. Infections  In Renal Transplant Patients. Subspecialty Conference at Fairview Hospital November, 1998
123. Analysis of Use of Cytomegalovirus (CMV) Immune Globulin (CMVIG) Plus IV Ganciclovir to Prevent Primary CMV Disease in Liver Transplants 10TH International Symposium on Infections in The Immunocompromised Host June, 1998
124. A randomized prospective trial of oral acyclovir vs. oral ganciclovir for CMV prophylaxis in high-risk kidney transplant recipients ASTP May, 1998
125. Sinus disease in allogeneic bone marrow transplant recipients 8th International Congress on Infectious Diseases May, 1998
126. Hypogammaglobulinemia as a possible cause of deterioration in lung transplant patients.  International Society for Heart and Lung Transplantation, April, 1998
127. Transplant Infectious Disease Lecture at Charleston Medical Center January, 1998
128. CMV Prevention in Transplantation. Lecture at West Virginia University Medical Center January, 1998
129. Prophylaxis of primary cytomegalovirus infection and disease after heart transplantation: does adding cytomegalovirus immune globulin to ganciclovir help? ASTP January, 1997
130. High prevalence of diarrhea but infrequency of documented C. difficile in autologous peripheral blood progenitor cell transplant recipients. ASTP January, 1997
131. A randomized prospective trial of single daily dose vancomycin and tobrmycin plus oral ciprofloxacin versus standard triple antibiotics in febrile neutropenic recipients of autologous progenitor cell transplants ASTP January, 1997
132. The yield of blood cultures in febrile autologous peripheral blood progenitor cell transplant recipients ASTP January, 1997
133. Infectious outcomes in transplantation in international patients IDSA 35th Annual Meeting January, 1997
134. Prophylaxis of invasive aspergillosis with itraconazole in allogeneic bone marrow transplant recpients; Preliminary results ASTP January, 1997
135. The disproportionate burden of CMV in lung transplant recipients. Oral presentation 16th ASTP Annual Meeting January, 1997
136. Infections in patients with long-term functioning renal  allografts International Transplant Meeting, Barcelona August, 1996
137. Cytomegalovirus prophylaxis with ganciclovir after heart transplantation.  American Society of Transplant Physicians (ASTP), 15th Annual Meeting May, 1996
138. Risk factors for invasive aspergillosis in lung transplant recipients IDSA 34th  Annual Meeting January, 1996
139. Routine cultures of bone marrow and peripheral stem cell harvests: clinical impact and cost analysis IDSA 34th Annual Meeting January, 1996
140. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant  recipients ever be discontinued?  IDSA 34th Annual Meeting January, 1996
141. Reconstitution of the Immune System after Bone Marrow Transplant Infectious Disease Grand Rounds, Cleveland Clinic Foundation September, 1995
142. Cytomegalovirus infection in seromismatched lung transplant  recipients with and without prophylaxis with CMV immunoglobulin Lung  Transplant meeting January, 1995
143. Role of Superantigens in Disease Causation Infectious Disease Grand Rounds,  Cleveland Clinic Foundation  January, 1995
144. AIDS among the homeless of Boston a cohort study Int Conf AIDS 1990; 6(2): Abstract no. F.B. 429 January, 1990



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Approach to Infectious Complications After Lung Transplantation Lung Summit: Innovations in Pulmonary and Critical Care Medicine August, 2010

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.